A forum for researchers, students and applicants in the field of cyclodextrin technology
Remdesivir, an investigational broad-spectrum antiviral agent, formulated with sulfobutyl beta-cyclodextrin, has shown in vitro activity against SARSCoV-2. Currently, remdesivir is
Pharmafile reports that Gilead’s antiviral therapy remdesivir has emerged as one of the most promising drugs to treat COVID-19 infections,
Science News reported on October 5, 2020 the opinion of Rajesh Gandhi, an infectious diseases physician at Massachusetts General Hospital
— Final Day 29 Data Show Superior Efficacy of Veklury Compared with Placebo in Hospitalized Patients Receiving Standard of Care
Már gőzerővel gyártják Magyarországon a koronavírus elleni egyik leghatékonyabb gyógyszert – erősítette meg a Richter az Index értesüléseit. A RICHTER
Since the COVID-19 pandemic began, Gilead has worked diligently to ramp up production and rapidly expand the supply of our
News Release on 23-Sep-2020 on Eurokalert Researchers at the University of Alberta have discovered a novel, second mechanism of action
Remdesivir exhibits in vitro activity against SARS-CoV-2 and was granted approval for Emergency Use. To maximize delivery to the lungs,
Gilead’s Investigational Antiviral Veklury® (Remdesivir) Receives U.S. Food and Drug Administration Emergency Use Authorization for the Treatment of Patients With
The paper published in Journal of the American Society of Nephrology (JASN) is an expert opinion on the risks of
